Medi-Physics' Ceretec imaging agent launch set for in mid-June for detecting infections.
Executive Summary
MEDI-PHYSICS CERETEC NEW FORMULATION WILL BE LAUNCHED at the Society of Nuclear Medicine's annual meeting June 12-15 in Minneapolis. Three improvements of the diagnostic imaging agent Ceretec (technetium Tc99m exametazime) were approved April 7 through two efficacy supplements. The new formulation of Ceretec will replace the original version that was approved by FDA in December 1988 for stroke imaging with single photon emission computed tomography, Medi-Physics said.